A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In cases of Alzheimer's presenile and senile dementia, Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT), respectively, we have observed, in addition to the gray matter degeneration, a lesion that has the character of an incomplete infarction confined to the white matter. It is encountered in 60% of both groups, with mild changes in two thirds and moderate or severe changes in one third. It involves the deep white matter symmetrically, tapering off toward the cortex. It is characterized by partial loss of myelin, axons, and oligodendroglial cells; mild reactive astrocytic gliosis; and sparsely distributed macrophages as well as stenosis resulting from hyaline fibrosis of arterioles and smaller vessels. No complete or cavitating infarctions and no hypertensive vascular changes were observed. The white matter changes are thought to be due to hypoperfusion of the concerned white matter territories since, in addition to the white matter hyaline vascular stenosis, these cases show signs of cardiovascular disease, usually with hypotension. The white matter disorder also occurs independent of the gray matter process of AD and SDAT and may be seen as the sole brain lesion in non‐AD subjects. Its occurrence is thus neither regularly related to the severity nor to the regional appearance and accentuation of the cortical Alzheimer process and is thus not likely to be just the result of a wallerian degeneration. Histologically it is similar in several respects to Binswanger's disease, although with some distinct differences. It is thus related to the cerebrovascular group of disorders in addition to AD and SDAT. In view of its frequency and severity, this white matter lesion is important to define, to diagnose, and ultimately to prevent or cure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“White matter degeneration and microbleeds most likely reflect direct tissue damage,71,78–80”
In the citing paper
“white matter degeneration is related to Alzheimer disease pathology78”
In the citing paper
“white matter degeneration is related to Alzheimer disease pathology78 and microbleeds to CAA.”
In the citing paper
“In Alzheimer’s disease, white matter degeneration is a frequent structural brain change apart from grey matter atrophy (Brun and Englund, 1986).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Brun and Englund, 1986
In the citing paper
“Such white matter alterations cannot be fully accounted for as degenerative processes secondary to grey matter damage (Brun and Englund, 1986; Englund, 1998; Agosta et al., 2011), but may stem from vascular amyloid deposition and microvascular damage (Weller et al., 2009).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Brun and Englund, 1986
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Lipcsey, A. (1980) · PubMed · Cited by 1,083
Walton, J. N. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90157-x · Cited by 964
Distribution and fatty acid composition of phosphoglycerides in normal human brain
Svennerholm, L. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42702-6 · Cited by 639
Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading
BRUN, A., & ENGLUND, E. (1981) · Histopathology · doi:10.1111/j.1365-2559.1981.tb01818.x · Cited by 561
Self-citationDistribution of cerebral degeneration in Alzheimer's disease: A clinico-pathological study
Brun, A., & Gustafson, L. (1976) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00367450 · Cited by 397
Self-citationClinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease)
Caplan, L. R., & Schoene, W. C. (1978) · Neurology · doi:10.1212/wnl.28.12.1206 · Cited by 282
Computed Tomography in the Elderly 2. Senile Dementia: Diagnosis and Functional Impairment
Jacoby, R. J., & Levy, R. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.3.256 · Cited by 205
Goto, K., Ishii, N., & Fukasawa, H. (1981) · Radiology · doi:10.1148/radiology.141.3.7302224 · Cited by 181
OLSZEWSKI, J. (1962) · PubMed · Cited by 161
Subcortical arteriosclerotic encephalopathy: a clinical and radiological investigation.
Loizou, L. A., Kendall, B. E., & Marshall, J. (1981) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.4.294 · Cited by 139
Research works printed but not linked: 6
- Auff E, 1980, Contribution to the problem of presenile glial dystrophy, Neuropathology, 1, 113
- Binswanger O, 1984, Die Abgrenzung der allgemeinen progressiven Paralyse, Berl Klin Wochenschr, 31, 1103
- 1981, Editorial 1981.: Binswanger's encephalopathy, Lancet, 1, 923
- George AE, 1981, Parenchymal CT correlates of senile dementia (Alzheimer's disease): loss of grey‐white matter discriminability, AJNR, 2, 205
- Gustafson L, 1984, Proceedings of the VII World Congress of Psychiatry 1983
- Sternby NH, 1968, Atherosclerosis in a defined population, Acta Pathol Microbiol Scand Suppl, 194
Cited by
Items 201–300 of 1,000
Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease
Ellison, D. W., Beal, M. F., & Martin, J. B. (1987) · Brain Research · doi:10.1016/0006-8993(87)90471-9 · Cited by 124
Relationship between vascular factors and white matter low attenuation of the brain
Räihä, I., Tarvonen, S., Kurki, T., Rajala, T., & Sourander, L. (1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb05509.x · Cited by 118
Quantitative MR Imaging in Alzheimer Disease
Ramani, A., Jensen, J. H., & Helpern, J. A. (2006) · Radiology · doi:10.1148/radiol.2411050628 · Cited by 111
White matter lesion in the elderly
Meyer, J. S., Kawamura, J., & Terayama, Y. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90002-3 · Cited by 121
Nowrangi, M. A., Lyketsos, C. G., Leoutsakos, J. S., Oishi, K., Albert, M., Mori, S., & Mielke, M. M. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.05.2186 · Cited by 120
“Decreasing FA is thought to represent changes in tissue cytoarchitecture due to a variety of causes, including vascular alteration, demyelination, and possibly gliosis [39,40].”
BackgroundYasmin, H., Nakata, Y., Aoki, S., Abe, O., Sato, N., Nemoto, K., Arima, K., Furuta, N., Uno, M., Hirai, S., et al. (2008) · Neuroradiology · doi:10.1007/s00234-007-0353-7 · Cited by 120
Hypertension, hypertension-clustering factors and Alzheimer's disease
Skoog, I., & Gustafson, D. (2003) · Neurological Research · doi:10.1179/016164103101201986 · Cited by 109
Dementia due to vascular disease--a multifactorial disorder.
Scheinberg, P. (1988) · Stroke · doi:10.1161/01.str.19.10.1291 · Cited by 113
O'Dwyer, L., Lamberton, F., Bokde, A. L. W., Ewers, M., Faluyi, Y. O., Tanner, C., Mazoyer, B., O'Neill, D., Bartley, M., Collins, D. R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021745 · Cited by 119
“WM changes may be a key indicator of early pathology [4] and WM damage in AD has been highlighted both in postmortem studies [5] as well as in vivo MRI studies [6,7].”
BackgroundPaola, M. D., Luders, E., Iulio, F. D., Cherubini, A., Passafiume, D., Thompson, P. M., Caltagirone, C., Toga, A. W., & Spalletta, G. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.050 · Cited by 119
Free Water in White Matter Differentiates MCI and AD From Control Subjects
Dumont, M., Roy, M., Jodoin, P.-M., Morency, F. C., Houde, J.-C., Xie, Z., Bauer, C., Samad, T. A., Van Dijk, K. R. A., Goodman, J. A., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00270 · Cited by 106
Diffusion-Weighted Magnetic Resonance Imaging in Alzheimer’s Disease
Sandson, T. A., Felician, O., Edelman, R. R., & Warach, S. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017099 · Cited by 112
The blood brain barrier in Alzheimer’s disease
Chakraborty, A., de Wit, N. M., van der Flier, W. M., & de Vries, H. E. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2016.11.008 · Cited by 118
O'Dwyer, L., Lamberton, F., Bokde, A. L. W., Ewers, M., Faluyi, Y. O., Tanner, C., Mazoyer, B., O'Neill, D., Bartley, M., Collins, D. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032441 · Cited by 117
“Although WM damage has been found in AD both in postmortem studies [8] and in vivo studies [9] little attention has been focused on the potential of using DTI tools to classify MCI and AD subjects.”
BackgroundAge‐Associated White Matter Lesions: The MRC C ognitive Function and Ageing Study
Wharton, S. B., Simpson, J. E., Brayne, C., & Ince, P. G. (2015) · Brain Pathology · doi:10.1111/bpa.12219 · Cited by 103
Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study
Bozzali, M., Falini, A., Cercignani, M., Baglio, F., Farina, E., Alberoni, M., Vezzulli, P., Olivotto, F., Mantovani, F., Shallice, T., et al. (2005) · Brain · doi:10.1093/brain/awh493 · Cited by 111
Zhan, X., Jickling, G. C., Ander, B. P., Stamova, B., Liu, D., Kao, P. F., Zelin, M. A., Jin, L.-W., DeCarli, C., & Sharp, F. R. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-142013 · Cited by 102
SODERLUND, H., Nyberg, L. H., Adolfsson, R., NILSSON, L., & Launer, L. J. (2003) · Cortex · doi:10.1016/s0010-9452(08)70879-7 · Cited by 116
Zuccalà, G., Onder, G., Pedone, C., Cocchi, A., Carosella, L., Cattel, C., Carbonin, P. U., & Bernabei, R. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.1.109 · Cited by 116
Cremers, L. G. M., de Groot, M., Hofman, A., Krestin, G. P., van der Lugt, A., Niessen, W. J., Vernooij, M. W., & Ikram, M. A. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.021 · Cited by 115
White Matter Changes in the Gerbil Brain Under Chronic Cerebral Hypoperfusion
Kurumatani, T., Kudo, T., Ikura, Y., & Takeda, M. (1998) · Stroke · doi:10.1161/01.str.29.5.1058 · Cited by 103
Waldemar, G., Bruhn, P., Kristensen, M., Johnsen, A., Paulson, O. B., & Lassen, N. A. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.3.285 · Cited by 109
Pathological Correlates of White Matter Hyperintensities on Magnetic Resonance Imaging
Shim, Y. S., Yang, D.-W., Roe, C. M., Coats, M. A., Benzinger, T. L., Xiong, C., Galvin, J. E., Cairns, N. J., & Morris, J. C. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000366411 · Cited by 103
Wakita, H., Tomimoto, H., Akiguchi, I., & Kimura, J. (1995) · Stroke · doi:10.1161/01.str.26.8.1415 · Cited by 103
Erkinjuntti, T., Benavente, O., Eliasziw, M., Munoz, D. G., Sulkava, R., Haltia, M., & Hachinski, V. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550040053014 · Cited by 106
Gorelick, P. B. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540070034011 · Cited by 93
The decline and resurgence of vascular dementia.
Hachinski, V. C. (1990) · Europe PMC (PubMed Central) · Cited by 116
Gold, B. T., Powell, D. K., Andersen, A. H., & Smith, C. D. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.05.036 · Cited by 112
Vascular Dementia Is Overdiagnosed
Brust, J. C. M. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310117026 · Cited by 103
Eyeing central neurons in vascular growth and reparative angiogenesis
Sapieha, P. (2012) · Blood · doi:10.1182/blood-2012-04-396846 · Cited by 106
White Matter Lesions and Disequilibrium in Older People: II. Clinicopathologic Correlation
Baloh, R. W. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540340067014 · Cited by 63
Bartzokis, G., Lu, P. H., Geschwind, D. H., Tingus, K., Huang, D., Mendez, M. F., Edwards, N., & Mintz, J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.024 · Cited by 109
Dyrba, M., Barkhof, F., Fellgiebel, A., Filippi, M., Hausner, L., Hauenstein, K., Kirste, T., Teipel, S. J., & the EDSD study group (2015) · Journal of Neuroimaging · doi:10.1111/jon.12214 · Cited by 97
Sjöbeck, M., Haglund, M., & Englund, E. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1384 · Cited by 96
Self-citationNovel MRI techniques in the assessment of dementia
Teipel, S. J., Meindl, T., Grinberg, L. T., Heinsen, H., & Hampel, H. J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0703-z · Cited by 109
Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers
Nierenberg, J., Pomara, N., Hoptman, M. J., Sidtis, J. J., Ardekani, B. A., & Lim, K. O. (2005) · NeuroReport · doi:10.1097/01.wnr.0000174058.49521.16 · Cited by 99
Diffusion-MRI in neurodegenerative disorders
Goveas, J., O’Dwyer, L., Mascalchi, M., Cosottini, M., Diciotti, S., De Santis, S., Passamonti, L., Tessa, C., Toschi, N., & Giannelli, M. (2015) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2015.04.006 · Cited by 104
The basis for choice reaction time slowing in Alzheimer's disease
Gordon, B., & Carson, K. J. (1990) · Brain and Cognition · doi:10.1016/0278-2626(90)90047-r · Cited by 106
MacKay, S., Meyerhoff, D. J., Constans, J.-M., Norman, D., Fein, G., & Weiner, M. W. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020079018 · Cited by 96
Rosenberg, G. A., Bjerke, M., & Wallin, A. (2014) · Stroke · doi:10.1161/strokeaha.113.004534 · Cited by 97
McAleese, K. E., Miah, M., Graham, S., Hadfield, G. M., Walker, L., Johnson, M., Colloby, S. J., Thomas, A. J., DeCarli, C., Koss, D., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02376-2 · Cited by 98
Teipel, S. J., Pogarell, O., Meindl, T., Dietrich, O., Sydykova, D., Hunklinger, U., Georgii, B., Mulert, C., Reiser, M. F., Möller, H., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20652 · Cited by 89
Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease
Dorfman, V. B., Pasquini, L., Riudavets, M., López-Costa, J. J., Villegas, A., Troncoso, J. C., Lopera, F., Castaño, E. M., & Morelli, L. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.016 · Cited by 90
Wallin, A., Edman, Å., Blennow, K., Gottfries, C.-G., Karlsson, I., Regland, B., & Sjögren, M. (1996) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879600900406 · Cited by 99
Cognitive Impairment and Cellular/Vascular Changes in the Cerebral White Mattera
PANTONI, L., & GARCIA, J. H. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48463.x · Cited by 94
Decreased myelin lipids in Alzheimer's disease and vascular dementia
Wallin, A., Gottfries, C. G., Karlsson, I., & Svennerholm, L. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03886.x · Cited by 97
van Zagten, M., Lodder, J., & Kessels, F. (1998) · Movement Disorders · doi:10.1002/mds.870130119 · Cited by 100
Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease
de la Monte, S. M., Wells, S. E., Hedley‐Whyte, E. T., & Growdon, J. H. (1989) · Annals of Neurology · doi:10.1002/ana.410260302 · Cited by 100
A Review on Blood Pressure and Ischaemic White Matter Lesions
Skoog, I. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051184 · Cited by 92
Harrell, L. E., Duvall, E., Folks, D. G., Duke, L., Bartolucci, A., Conboy, T., Callaway, R., & Kerns, D. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530230044019 · Cited by 96
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up
Scola, E., Bozzali, M., Agosta, F., Magnani, G., Franceschi, M., Sormani, M. P., Cercignani, M., Pagani, E., Falautano, M., Filippi, M., et al. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.189639 · Cited by 98
Cerebrovascular Effects of Amyloid-ß Peptides: Mechanisms and Implications for Alzheimer's Dementia
Iadecola, C. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025092617651 · Cited by 97
Tian, J., Shi, J., Bailey, K., & Mann, D. M. A. (2004) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00510.x · Cited by 89
White matter alterations in early‐stage Alzheimer's disease: A tract‐specific study
Wen, Q., Mustafi, S. M., Li, J., Risacher, S. L., Tallman, E., Brown, S. A., West, J. D., Harezlak, J., Farlow, M. R., Unverzagt, F. W., et al. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.06.003 · Cited by 96
Cerebrovascular disorders: molecular insights and therapeutic opportunities
Storkebaum, E., Quaegebeur, A., Vikkula, M., & Carmeliet, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2947 · Cited by 96
The pathophysiological role of astrocytic endothelin-1
Hostenbach, S., D’haeseleer, M., Kooijman, R., & Keyser, J. D. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.009 · Cited by 96
Tract-based analysis of white matter degeneration in Alzheimer’s disease
Lee, S.-H., Coutu, J.-P., Wilkens, P., Yendiki, A., Rosas, H. D., & Salat, D. H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.049 · Cited by 88
Scarpelli, M., Salvolini, U., Diamanti, L., Montironi, R., Chiaromoni, L., & Maricotti, M. (1994) · Neuroradiology · doi:10.1007/bf00612126 · Cited by 96
Barber, R., Gholkar, A., Scheltens, P., Ballard, C., McKeith, I. G., & O'Brien, J. T. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200010)15:10<911::aid-gps217>3.0.co;2-t · Cited by 87
CT in the differential diagnosis between Alzheimer's disease and vascular dementia
Erkinjuntti, T., Ketonen, L., Sulkava, R., Vuorialho, M., & Palo, J. (1987) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1987.tb07931.x · Cited by 86
Skoog, I., Berg, S., Johansson, B., Palmertz, B., & Andreasson, L.-A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00190.x · Cited by 90
Alzheimer’s Disease Neuropathological Comorbidities are Common in the Younger-Old
Beach, T. G., & Malek-Ahmadi, M. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201213 · Cited by 84
Hypertension and the risk of dementia in the elderly
Forette, F., & Boller, F. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90430-6 · Cited by 96
Ksiezak-Reding, H., Binder, L. I., & Yen, S. H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68426-1 · Cited by 92
PASSANT, U., WARKENTIN, S., & GUSTAFSON, L. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199703)12:3<395::aid-gps527>3.0.co;2-# · Cited by 86
Relationship between blood pressure and Alzheimer's disease in Linxian County, China
Wu, C., Zhou, D., Chen, W., Zhang, L., Como, P. G., & Qiao, Y. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02367-6 · Cited by 93
Mehta, R. C., Pike, G. B., & Enzmann, D. R. (1996) · PubMed · Cited by 93
Amyloid β peptide-induced corpus callosum damage and glial activation in vivo
Jantaratnotai, N., Ryu, J. K., Kim, S. U., & McLarnon, J. G. (2003) · NeuroReport · doi:10.1097/00001756-200308060-00005 · Cited by 71
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 91
Functional relevant loss of long association fibre tracts integrity in early Alzheimer's disease
Fellgiebel, A., Schermuly, I., Gerhard, A., Keller, I., Albrecht, J., Weibrich, C., Müller, M. J., & Stoeter, P. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.12.010 · Cited by 91
Chen, T., Chen, Y., Cheng, T., Hua, M., Liu, H., & Chiu, M. (2009) · Human Brain Mapping · doi:10.1002/hbm.20810 · Cited by 85
Clinical features of leuko-araiosis.
Tarvonen-Schroder, S., Roytta, M., Raiha, I., Kurki, T., Rajala, T., & Sourander, L. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.4.431 · Cited by 84
Chetram Deochand, M. T. (2013) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000128 · Cited by 76
Spectrum of Disease in Vascular Cognitive Impairment
Rockwood, K., Howard, K., MacKnight, C., & Darvesh, S. (1999) · Neuroepidemiology · doi:10.1159/000026219 · Cited by 88
Gootjes, L., Bouma, A., Strien, J. W. V., van Schijndel, R. A., Barkhof, F., & Scheltens, P. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2005.05.002 · Cited by 89
Failure to Modulate Attentional Control in Advanced Aging Linked to White Matter Pathology
Hedden, T., Van Dijk, K. R. A., Shire, E. H., Sperling, R. A., Johnson, K. A., & Buckner, R. L. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr172 · Cited by 81
Improved Recognition of Leukoaraiosis and Cognitive Impairment in Alzheimer's Disease
Diaz, J. F., Merskey, H., Hachinski, V. C., Lee, D. H., Boniferro, M., Wong, C. J., Mirsen, T. R., & Fox, H. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530220038016 · Cited by 83
Risk factors for white matter changes detected by magnetic resonance imaging in the elderly.
Sullivan, P., Pary, R., Telang, F., Rifai, A. H., & Zubenko, G. S. (1990) · Stroke · doi:10.1161/01.str.21.10.1424 · Cited by 84
Magnetic Resonance Imaging and the Severity of Dementia in Older Adults
Bondareff, W. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810130049007 · Cited by 87
Diffusion tensor MRI to investigate dementias: a brief review
Bozzali, M., & Cherubini, A. (2007) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2007.03.017 · Cited by 89
Bradley, W. G., Bahl, G., & Alksne, J. F. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20684 · Cited by 88
Iron, Copper, and Zinc Distribution of the Cerebellum
Popescu, B. F. G., Robinson, C. A., Rajput, A. H., Rajput, A. H., Harder, S. L., & Nichol, H. K. (2009) · The Cerebellum · doi:10.1007/s12311-008-0091-3 · Cited by 88
Haglund, M., Sjöbeck, M., & Englund, E. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00725.x · Cited by 81
Self-citationIncomplete lacunar infarction (Type I b lacunes)
Lammie, G. A., Brannan, F., & Wardlaw, J. M. (1998) · Acta Neuropathologica · doi:10.1007/s004010050877 · Cited by 87
Deep-Learning-Based Diagnosis and Prognosis of Alzheimer’s Disease: A Comprehensive Review
Sharma, R., Goel, T., Tanveer, M., Lin, C., & Murugan, R. (2023) · IEEE Transactions on Cognitive and Developmental Systems · doi:10.1109/tcds.2023.3254209 · Cited by 88
Zeng, C., Lee, J. T., Chen, H., Chen, S., Hsu, C. Y., & Xu, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03217.x · Cited by 80
Myelin Injury and Degraded Myelin Vesicles in Alzheimer’s Disease
Zhan, X., Jickling, G., Ander, B., Liu, D., Stamova, B., Cox, C., Jin, L.-W., DeCarli, C., & Sharp, F. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140131120922 · Cited by 79
Zimpfer, D., Wieselthaler, G. M., Czerny, M., Fakin, R. M., Haider, D. G., Zrunek, P., Roethy, W., Schima, H., Wolner, E., & Grimm, M. F. (2006) · ASAIO Journal · doi:10.1097/01.mat.0000191334.51375.7e · Cited by 88
Park, J.-H., Seo, S. W., Kim, C., Kim, S. H., Kim, G. H., Kim, S. T., Jeon, S., Lee, J. M., Oh, S. J., Kim, J. S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.026 · Cited by 83
Utter, S., Tamboli, I. Y., Walter, J., Upadhaya, A. R., Birkenmeier, G., Pietrzik, C. U., Ghebremedhin, E., & Thal, D. R. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181836a71 · Cited by 80
B. Parente, D., Gasparetto, E. L., Cruz, L. C. H. D., Domingues, R. C., Baptista, A. C., Carvalho, A. C. P., & Domingues, R. C. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2617 · Cited by 78
Sydykova, D., Stahl, R., Dietrich, O., Ewers, M., Reiser, M. F., Schoenberg, S. O., Moller, H.-J., Hampel, H., & Teipel, S. J. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl136 · Cited by 84
van Zagten, M., Boiten, J., Kessels, F., & Lodder, J. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550070088015 · Cited by 80
The role of clinical neuropsychology in the neurological diagnosis of Alzheimer's disease
Spinnler, H. R., & Sala, S. D. (1988) · Journal of Neurology · doi:10.1007/bf00314172 · Cited by 87
Oligodendrocytes in Alzheimer’s disease pathophysiology
Kedia, S., & Simons, M. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01873-x · Cited by 86
“There is also neuropathological evidence supporting white matter alterations in AD, showing partial loss of myelin and axons, accompanied by reactive astrocytic gliosis, sparsely distributed myeloid cells and hyaline fibrosis of vessels 93 .”
Rigaud, A., & Forette, B. (2001) · The Journals of Gerontology Series A · doi:10.1093/gerona/56.4.m217 · Cited by 86
Leskovjan, A. C., Kretlow, A., & Miller, L. M. (2010) · Analytical Chemistry · doi:10.1021/ac1002728 · Cited by 86
The topographic distribution of brain atrophy in Alzheimer's disease
Mann, D. M. A. (1991) · Acta Neuropathologica · doi:10.1007/bf00294434 · Cited by 85
Lack of Relationship Between Leukoaraiosis and Carotid Artery Disease
Streifler, J. Y., Eliasziw, M., Benavente, O., Hachinski, V. C., Fox, A. J., Barnett, H. J. M., & Trial, N. A. S. C. E. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250025008 · Cited by 86
Román, G. C. (1996) · Stroke · doi:10.1161/01.str.27.8.1269 · Cited by 86
Metadata
- Authors
- Brun, A., & Englund, E.
- Affiliations
- Skåne University Hospital (SE)
- Corresponding author
- Brun, A.
- ORCID
- Englund, E.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1986-03
- Volume
- 19
- Issue
- 3
- Pages
- 253-262
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2017159332
- Cited by
- 1,014
- References
- 34
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 15 · 2023: 25 · 2022: 19 · 2021: 14 · 2020: 18 · 2019: 21 · 2018: 24 · 2017: 22 · 2016: 22 · 2015: 23 · 2014: 37 · 2013: 33 · 2012: 30
- FWCI
- 26.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- Alzheimer's disease, senile dementia of the Alzheimer type, white matter disease, deep white matter, demyelination, oligodendrocyte loss, astrocytic gliosis, cerebral hypoperfusion, cardiovascular disease, Binswanger disease, cerebrovascular disease, Wallerian degeneration
- MeSH terms
- Aged, Alzheimer Disease, Brain, Cardiovascular Diseases, Cerebral Infarction, Dementia, Humans, Middle Aged, Periaqueductal Gray, Severity of Illness Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.